naringenin has been researched along with Carcinoma, Epidermoid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, H; Fujiwara, Y; Gohara, S; Hirayama, M; Hirosue, A; Iwamoto, A; Kawaguchi, S; Kawahara, K; Komohara, Y; Maeshiro, M; Nagao, Y; Nagata, M; Nakashima, H; Nakayama, H; Ohnishi, K; Pan, C; Sakata, J; Yamana, K; Yano, H; Yoshida, R | 1 |
| Chang, TM; Chen, PH; Lee, CJ; Lin, JS; Liu, JF; Tsai, YJ; Wu, HM | 1 |
| Bhia, I; Bhia, M; Kasaii, MS; Mohammadkhani, N; Motallebi, M; Mueller, AL; Nouri-Majd, S; Paiva-Santos, AC; Pereira-Silva, M; Rajani, HF; Shakibaei, M; Tabarraei, H; Veiga, FJB | 1 |
| Gong, ZC; Li, CX; Tan, XR | 1 |
| Huang, XF; Jiao, X; Song, WX; Wang, K; Wu, P; Wu, WY; Xiao, PQ; Zhan, SF | 1 |
| Krishnakumar, N; Manoharan, S; Sulfikkarali, NK; Venkatachalam, P | 1 |
| Biffi, L; Gaini, R; Garavello, W; Maggioni, D; Nicolini, G; Pignataro, L; Rigolio, R | 1 |
| Afzal, M; Ahamad, MS; Ahmad, S; Arshad, M; Jafri, A; Siddiqui, S | 1 |
| Krishnakumar, N; Manoharan, S; Nirmal, RM; Sulfikkarali, N | 1 |
| Chang, HR; Chu, SC; Hsieh, YS; Kuo, WH; Yang, SF; Yang, WE | 1 |
1 review(s) available for naringenin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Naringenin: A potential flavonoid phytochemical for cancer therapy.
Topics: Carcinoma, Squamous Cell; Flavanones; Flavonoids; Humans; Male; Mouth Neoplasms; Phosphatidylinositol 3-Kinases; Phytochemicals | 2022 |
9 other study(ies) available for naringenin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Topics: Animals; Carcinoma, Squamous Cell; Flavanones; Interleukin-12; Lymph Nodes; Macrophage Activation; Mice; Mouth Neoplasms; Sialic Acid Binding Ig-like Lectin 1; T-Lymphocytes, Cytotoxic | 2022 |
Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Endoplasmic Reticulum Stress; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2022 |
Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2023 |
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Topics: Antiviral Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; COVID-19; Humans; Lung Neoplasms; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases | 2023 |
Raman spectroscopic investigation of the chemopreventive response of naringenin and its nanoparticles in DMBA-induced oral carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenesis; Carcinoma, Squamous Cell; Chemoprevention; Cricetinae; Flavanones; Fourier Analysis; Light; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Nanoparticles; Particle Size; Scattering, Radiation; Spectrum Analysis, Raman | 2013 |
Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin B1; Cyclin D1; Flavanones; Flavonoids; Humans; Mouth Neoplasms; Signal Transduction; Wound Healing | 2014 |
Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; Enzyme Induction; Flavanones; Humans; Intracellular Space; Membrane Potential, Mitochondrial; Reactive Oxygen Species | 2014 |
Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cheek; Chemoprevention; Cricetinae; Flavanones; Lipid Peroxidation; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Nanoparticles; Particle Size; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 2013 |
Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flavanones; Flavones; Flavonoids; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Plasminogen Activator Inhibitor 1; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tongue Neoplasms; Urokinase-Type Plasminogen Activator | 2008 |